Please assess the completion status of the following clinical trial:

Trial Title: BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with OSA still complaining EDS,refusing nCPAP~* ESS score ≥ 12~Exclusion Criteria:~* Patients suffering from insomnia without OSA~* Co-existing narcolepsy~* Patient with sleep debt not due to OSA~* Acute or chronic severe disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BF2.649 (Type: EXPERIMENTAL): BF2.649 capsules dosed at 5 mg, 10 mg, 20 mg
- Placebo (Type: PLACEBO_COMPARATOR): Capsules of placebo containing lactose with low, medium and high dosage

Based on this trial design, predict the completion outcome and termination type (if applicable).